Form 4 for SCL STEPAN CO
Accepted 2026-03-04 00:00:00 ET · period of report 2026-02-27 · accession 0000094049-26-000033 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-03-04 | 2026-02-27 | SCL | Moriarty Sean Thomas | VP, GM Surfactants | A - Grant | $52.51 | +56.77 | 14.2K | +0.4% | +$2,981 |
| DM | 2026-03-04 | 2026-03-02 | SCL | Moriarty Sean Thomas | VP, GM Surfactants | A - Grant | $0.00 | +13.9K | 4,495 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-02-27 | A | A | 56.77 | $52.51 | 14,205.23 | D | — | — | |
| 2 | Derivative | Stock Appreciation Right | 2026-03-02 | A | A | 7,155 | $0.00 | 7,155 | D | $17.47 · 2027-03-02 to 2036-03-03 | 7,155 Common Stock | (F1) Vest ratably over three years beginning on the date shown. |
| 3 | Derivative | Performance Shares | 2026-03-02 | A | A | 2,247 | $0.00 | 2,247 | D | — · — to — | 2,247 Common Stock | (F3) Each performance share represents a contingent right to receive one share of Stepan Company common stock. (F4) The performance shares vest upon the certification of Stepan Company achieving certain performance goals for the performance period ending December 31, 2028. |
| 4 | Derivative | Restricted Stock Units | 2026-03-02 | A | A | 4,495 | $0.00 | 4,495 | D | — · 2027-03-02 to 2029-03-02 | 4,495 Restricted Stock Units | (F2) Each restricted stock unit ("RSU") represents a contingent right to receive one share of Stepan Company common stock. (F1) Vest ratably over three years beginning on the date shown. |